These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1180 related articles for article (PubMed ID: 15949105)

  • 1. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP; Din S; Atlas MD
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
    Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
    Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S; Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the Meniett device in patients with Ménière's disease: long-term results.
    Dornhoffer JL; King D
    Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
    Gates GA; Green JD; Tucci DL; Telian SA
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meniett clinical trial: long-term follow-up.
    Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical long-term effects of surgical treatment for intractable Meniere's disease: a more than 13-year follow-up after pressure treatment and further surgical treatment for intractable vertigo.
    Liu F; Huang W; Chen K
    Acta Otolaryngol; 2019 Dec; 139(12):1053-1057. PubMed ID: 31556757
    [No Abstract]   [Full Text] [Related]  

  • 10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Ménière's disease.
    Schlegel M; Vibert D; Ott SR; Häusler R; Caversaccio MD
    Otol Neurotol; 2012 Oct; 33(8):1380-5. PubMed ID: 22931868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
    Gates GA; Green JD
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Ménière's disease.
    Nabi S; Parnes LS
    Curr Opin Otolaryngol Head Neck Surg; 2009 Oct; 17(5):356-62. PubMed ID: 19617826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
    Buchanan MA; Rai A; Prinsley PR
    J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.